icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Covid-19 vaccine developments pushing US dollar lower

Covid-19 vaccine developments pushing US dollar lower
The US currency continued to weaken on Monday as promising news on coronavirus vaccine rollouts have been weighing on the greenback. Experts say that traders’ appetite for riskier assets is growing.

The dollar was trading down 0.1 percent versus a basket of currencies at 92.234, dropping to a two-and-a-half-year low.

“Markets are following pandemic news at the moment – vaccine optimism seems to be supporting risk assets for the time being,” chief economist at UBS Global Wealth Management Paul Donovan was quoted as saying in a note to clients.

The British drugmaker AstraZeneca said on Monday its vaccine could be around 90 percent effective as late-stage trials showed. The company said it will prepare submission of data to authorities around the world that have a framework for conditional or early approval.

Also on rt.com ‘The world is going back to a GOLD STANDARD as the US dollar is about to collapse’ – Peter Schiff

The announcement follows a string of positive vaccine developments by other global drugmakers. Earlier this month US-based biotechnology company Moderna said its experimental vaccine was 94.5 percent effective in preventing Covid-19, based on interim data from a late-stage clinical trial. A rival vaccine by US-based Pfizer and German firm BioNTech was found to have efficacy of 90 percent, while the developers of Russia’s Sputnik V vaccine reported a 92 percent efficacy.

Citibank warned last week that the widespread distribution of vaccines to combat the coronavirus pandemic and ongoing monetary easing could lead to the US dollar weakening as much as 20 percent next year.

For more stories on economy & finance visit RT's business section

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.

Podcasts